- Home
- HCKT vs ZVRA Comparison
HCKT vs ZVRA Comparison
Compare HCKT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCKT
- ZVRA
- Stock Information
- Founded
- HCKT 1991
- ZVRA 2006
- Country
- HCKT United States
- ZVRA United States
- Employees
- HCKT N/A
- ZVRA N/A
- Industry
- HCKT Professional Services
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- HCKT Consumer Discretionary
- ZVRA Health Care
- Exchange
- HCKT Nasdaq
- ZVRA Nasdaq
- Market Cap
- HCKT 636.1M
- ZVRA 627.7M
- IPO Year
- HCKT 1998
- ZVRA 2015
- Fundamental
- Price
- HCKT $21.09
- ZVRA $9.44
- Analyst Decision
- HCKT Strong Buy
- ZVRA Strong Buy
- Analyst Count
- HCKT 3
- ZVRA 10
- Target Price
- HCKT $29.67
- ZVRA $22.67
- AVG Volume (30 Days)
- HCKT 361.4K
- ZVRA 1.6M
- Earning Date
- HCKT 08-05-2025
- ZVRA 08-12-2025
- Dividend Yield
- HCKT 2.32%
- ZVRA N/A
- EPS Growth
- HCKT N/A
- ZVRA N/A
- EPS
- HCKT 0.59
- ZVRA N/A
- Revenue
- HCKT $309,265,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- HCKT $6.06
- ZVRA $303.00
- Revenue Next Year
- HCKT $5.46
- ZVRA $77.66
- P/E Ratio
- HCKT $35.01
- ZVRA N/A
- Revenue Growth
- HCKT 3.98
- ZVRA 161.81
- 52 Week Low
- HCKT $19.39
- ZVRA $6.19
- 52 Week High
- HCKT $34.02
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- HCKT 42.97
- ZVRA 39.30
- Support Level
- HCKT $19.93
- ZVRA $8.91
- Resistance Level
- HCKT $20.82
- ZVRA $10.15
- Average True Range (ATR)
- HCKT 0.72
- ZVRA 0.65
- MACD
- HCKT 0.03
- ZVRA -0.22
- Stochastic Oscillator
- HCKT 43.70
- ZVRA 22.80
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.